In some experiments, sorbitol (5.5 mM) was included in the perfusate to measure circulating volume.
The details of the conditions and methods of monitoring heart perfusion, together with the methods of sample collection, were as described by Chain et al. (1) . Working heart preparations were perfused via the left atrium.
The aortic output was used as an index of the stability of the work performance.
The Langendorff recirculation system is one in which there is recirculation of 50 ml of perfusion fluid, and the perfusion pressure is 100 cm of water. The working recirculation system was studied at an atria1 pressure of 20 cm water; the left ventricle spontaneously ejected 40-60 ml of perfusate per minute against a hydrostatic pressure of 100 cm of water. Perfusion was terminated by freezing the heart between aluminum clamping blocks cooled in liquid nitrogen (3 1). The frozen muscle was then powdered in a percussion mortar at liquid nitrogen temperature.
This powder was used for enzyme extraction, glycogen, and dry weight determination. Performance of the heart and the effect of insulin was checked by comparing the values of glucose uptake among normal, diabetic, and insulin-treated hearts. A portion of the frozen powder was used for dry weight determination.
A second portion was used for the isolation of glycogen by the method of Good et al. (11) . A third portion was homogenized in 1 ml of ice-cold 6 % (w/v) HClO4, centrifuged, and reextracted with the same volume of HClOd.
The combined filtrate was filtered through a Millipore filter (0.8 pm porosity), neutralized with KOH to pH 7.0, and used for the enzymic determination of glucose 6-phosphate, glucose 1 -phosphate, and UDPglucose, as described by Das et al. (6) . Protein was determined by the method of Lowry et al. (21).
Enzyme Extraction and Assay a) Hexokinase. Frozen powdered hearts (1 g in 3 ml) were extracted twice with the extraction buffer, 20 mM Tris-HCI (pH 7.5) containing 0.115 M KC1 and 10 mM MgClz, and centrifuged at 500 X g. The combined supernatants were used for total activity determination.
A portion of this supernatant was centrifuged at 100,000 X g for the determination of soluble hexokinase activity. A further portion of the supernatant was dialyzed for 1 hr for the determination of the activity of hexokinase types I and II. Hexokinase types I and II were distinguished by their different stabilities to heat treatment at 45 C for 1 hr in the absence of glucose (12). The type I isoenzyme is resistant to heat treatment, whereas type II lost over 90 % of its activity with the same treatment. Hexokinase type III activity has been shown to be inhibited by high glucose concentration (12). Therefore, in some cases hexokinase type III activity was determined in the presence of 0.5 mM and 0.1 M glucose, the difference in activity between these being an estimate of hexokinase type III activity. No significant hexokinase type III activity was observed in normal or diabetic rat hearts. b) Glycogen synthetase. A portion of the frozen powder was homogenized in ice-cold buffer containing 10 mM EDTA, 50 mM KF, and 10 mM Tris-HCI buffer, pH 7.0, (1 g of powder to 4 ml) in a Vortex mixer. A second extraction was done with the same volume of buffer. Some extractions were performed with 60 % (w/v) glycerol, but this did not change their effectiveness significantly.
Glycogen synthetase activity was determined as described by Villar-Palasi et al. (29) by measuring the incorporation of radioactive glucoseJ4C from UDPglucose -14C into glycogen. Tubes with 0.1 ml of the synthetase assay mixture containing 6.7 mM UDPglucose-14C (SA 50,000 dpm/pmole), 1 mg of rabbit liver glycogen, and 50 mM Tris-HCl (pH 7.8) were prepared, 0.05 ml of heart extract containing the enzyme was added, and incubation was carried out at 30 C for 10 min in the presence and absence of glucose 6-phosphate (10 mM). The reaction was stopped by adding 1.0 ml of 6 % (w/v) trichloroacetic acid (TCA) containing 1 mg/ml glycogen and 2 mg/ml LiBr. Glycogen was isolated and the radioactivity was counted in a Packard model 3003 liquid scintillation counter with the use of 10 ml of scintillant (28). c) Phos$horyZase. For assay of phosphorylase, a portion of the powdered heart was homogenized with 2 ml 60 % (w/v) glycerol (pH 6.1) containing 20 mM NaF and 1 mM EDTA in a Vortex mixer at -25 C. The glycerol extract was then diluted (1 g in 60 ml) with 35 mM glycerophosphate, 30 mM cysteine, 1 mM EDTA, and 20 FM NaF buffer (pH 6.1). Phosphorylase activity was estimated after centrifuging the extract at 10,000 X g by measuring the release of inorganic phosphate at 30 C. The reaction mixture contained 16 mM glucose l-phosphate with and without AMP ( 1 mM), 1% (w/v) glycogen (which had previously been shaken with Dowex l-Cl), and 0.2 ml of heart extract (2). After 10 min the reaction was stopped by the addition of 1 ml of ice-cold 20 % (w/v) TCA. rats and the effect of insulin addition in the perfusate. Work did not have much effect on the total activity of this enzyme, but it significantly reduced the soluble type II hexokinase. Diabetes reduced the amount of total, soluble, and soluble type I I hexokinase.
The reduction of soluble hexokinase was due to the reduction of soluble type II hexokinase, which is evident from the constant level of soluble type I hexokinase in all conditions.
There was also a reduction in particulate-bound enzyme in diabetes (calculated by substracting soluble from the total); this may have been due to a loss of particulate type II hexokinase isoenzyme. Insulin in the perfusate (in our experimental conditions) did not significantly change the level of hexokinase isoenzyme type II in perfused heart, but it did prevent the decline of isoenzyme type II hexokinase due to heart work. The propor-or to anti-insulin serum treatment. Synthetase I activity increased significantly with heart work. No change in the amount of synthetase I activity was observed in streptozototin or anti-insulin-treated diabetic rats. Insulin in the perfusate was not able to increase the synthetase I portion of the glycogen synthetase. The results in Table 3 show that insulin in vivo can activate glycogen synthetase I within a very short time. A significant increase of the percent of total synthetase constituted by synthetase I was observed within 30 min after an injection of insulin. (Table 3) .
The above results on perfused hearts show that there does not appear to be a direct control of glycogen synthetase by insulin (14). The change of I/D ratio found in vivo may be the consequence of the production of a 'csecond messenger" which is controlled by insulin. The study of phosphorylase in our experiments shows that its activity is unaffected by heart work or insulin. The tissue content of glycogen precursors is low when compared with that found in other organs (Table 5 ). There is no other information regarding the levels of the above metabolites in perfused hearts except for glucose 6-phosphate and glycolytic intermediates (26). In general, the effect of insulin on glucose 6-phosphate, glucose 1 -phosphate, and UDPglucose was the same, irrespective of the performance
